A Monthly Dosed GLP-1 Analog for Treatment of Type 2 Diabetes Mellitus.

被引:0
|
作者
Cleland, J. L. [1 ]
Geething, N. [2 ]
To, W. [2 ]
Spink, B. [2 ]
Lee, L. [2 ]
Yao, Y. [2 ]
Silverman, J. [2 ]
机构
[1] Versartis Inc, Mountain View, CA USA
[2] Amunix Inc, Mountain View, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study
    Lassen, M. C. H.
    Johansen, N. D.
    Modin, D.
    Catarig, A. M.
    Vistisen, B. K.
    Amadid, H.
    Zimmermann, E.
    Gislason, G.
    Biering-Soerensen, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [43] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590
  • [44] Liraglutide: A human GLP-1 analogue for the treatment of type 2 diabetes
    Sakauye, Stacie D.
    Shah, Sachin A.
    FORMULARY, 2009, 44 (05) : 136 - +
  • [45] GLP-1 engineering in yeast for the Type 2 diabetes treatment.
    Egel-Mitani, M
    Nielsen, PF
    YEAST, 2003, 20 : S313 - S313
  • [46] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [47] The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes
    van der Klauw, M. M.
    Wolffenbuttel, B. H. R.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (10): : 436 - 443
  • [48] GLP-1 ANALOGUES FOR THE TREATMENT OF TYPE 2 DIABETES IN LATINOS/HISPANICS
    Caballero, A. Enrique
    ENDOCRINE PRACTICE, 2016, 22 (12) : 1459 - 1461
  • [49] Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
    Briones, Mariele
    Bajaj, Mandeep
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) : 1055 - 1064
  • [50] Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
    Mabilleau, Guillaume
    ENDOCRINE, 2015, 48 (01) : 1 - 2